XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Research and development expenses, net $ 623 $ 339 $ 1,753 $ 900
General and administrative expenses 1,130 896 3,407 2,830
Operating loss (1,753) (1,235) (5,160) (3,730)
Financing income (expenses), net 4 48 49 (2,272)
Net loss $ (1,749) $ (1,187) $ (5,111) $ (6,002)
Net loss per share, basic and diluted [1] $ (0.58) $ (0.45) $ (1.69) $ (2.25)
Weighted-average number of common shares outstanding, basic and diluted [1] 2,947,633 2,383,327 2,876,020 2,061,331
[1] September 30, 2017 share data represents the number of shares adjusted to retroactively reflect the 1:15 reverse stock split effected on September 4, 2018.